Physician profile
Roberto E Sanchez
NPI 1801844717
$6,915.12
in general payments reported to CMS, 2019-2025
39 companies · $1,624 in 2025
The $1,624 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $21.99 · 2021: $360 · 2022: $680 · 2023: $2,082 · 2024: $1,994 · 2025: $1,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,700.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $998.83 | 2023-2025 | |
| Abbvie INC. | $949.73 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Ucb, INC. | $785.37 | 2020-2025 | Briviact, Rystiggo, Nayzilam |
| Neurocrine Biosciences, INC. | $606.59 | 2022-2024 | Ingrezza, Ongentys |
| Boston Scientific Corporation | $385.15 | 2019-2023 | Watchman Flx, Watchman Access System |
| Pfizer INC. | $381.58 | 2019-2025 | |
| Lilly USA, LLC | $291.13 | 2021-2025 | Amyvid, Emgality, Kisunla |
| Argenx US, INC. | $275.97 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Atricure, INC. | $272.31 | 2023 | |
| Abbott Laboratories | $266.10 | 2023-2024 | Amplatzer Talisman, Jot Dx, Infinity |
| Neurelis, INC. | $161.18 | 2022-2025 | Valtoco |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $157.32 | 2023-2025 | Caplyta |
| Amgen INC. | $154.62 | 2022-2025 | Uplizna |
| Sumitomo Pharma America, INC. | $150.10 | 2023-2024 | Aptiom |
| Sk Life Science, INC. | $112.66 | 2024-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.